Drugs for the treatment of CHF, HTN, angina and HLD Flashcards

1
Q

Digoxin MOA

A

Inhibits the Na/K ATPase at the potassium binding site (less Na so more Ca) to increase contractility. Reduces HR (decreases SNS tone which prevails in CHF). Increases CO in the failing heart.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Digoxin Main Effect

A

Positive Inotrope for CHF.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Digoxin Side Effects

A

Narrow margin of safety. Earliest sign of toxicity is GI upset. CNS effects. Cardiac arrhythmias are the most common and most dangerous: Bigeminy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Treatment of Digoxin toxicity

A

Discontinue or reduce amount of digoxin. Moderate toxicity: oral/IV potassium. Severe: Digitalis immune Fab with potassium.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

increased Digoxin toxicity

A

Hypokalemia (loops/thiazides and diarrhea)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Phosphodiesterase Inhibitors MOA

A

Inhibit cAMP phosphodiesterase to increase cAMP leading to more calcium influx and stronger contraction with significant vasodilation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Inamrinone

A

Phosphodiesterase Inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Milrinone

A

Phosphodiesterase Inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Phosphodiesterase Inhibitors Indication

A

Acute heart failure. Increases CO as a last ditch effeort

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Drugs that Reduce CHF mortality

A

Aldosterone antagonists, beta blockers, ACE-I and ARBs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Dopamine Indications

A

Severe refractory CHF. At a moderate dose will bind beta 1 receptors in the heart. IV only.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Dobutamine (Dobutrex)

A

Beta-1 agonist that is a positive inotrope (less tachycardia). Decreases filling pressure and increases oxygen consumption. IV only.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Diuretics Used for CHF

A

Spironolactone and Eplerenone (aldosterone antagonists). Reduces mortality rate in CHF. Decreases venous pressure to decrease edema and cardiac size.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

DOC for CHF

A

ACE inhibitors (-prils). Reduces mortality.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

ACE inhibitors MOA

A

“-prils” Inhibits ACE to stop conversion of angiotensin I to angiotensin II. Decreases afterload (Less angio II induced vasoconstriction) and decreases preload (less aldosterone) decreases cardiac remodeling.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

ACE inhibitor Side Effects

A

Dry cough and angioedema due to increases in bradykinin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Angiotensin II receptor blockers (ARB) MOA

A

“-sartans” Block the binding of angiotensin II to the AT1 receptor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Beta-Blockers and CHF

A

Decreases renin secretion, attenuates catecholamine effects, decreases HR, stops cardiac remodeling. Decreases mortality. Only use in the early stages due to negative inotropic effect. Carvedilol and metoprolol.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Vasodilators used for CHF

A

Sodium nitroprusside (nitropress), Isosorbide dinitrate, hydralazine (SLE causing). Decrease preload, afterload and cardiac remodeling.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

DOC for HTN

A

Thiazides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Adverse effects of thiazides

A

Reduced glucose tolerance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Thiazide contraindication

A

Diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Clonidine

A

Centrally acting sympatholytic.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Methyldopa

A

Centrally acting sympatholytic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Centrally acting sympatholytic MOA

A

Bind alpha 2 adrenergic receptors to decrease neurotransmitter release and decrease peripheral SNS activity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Centrally acting sympatholytic Effects

A

Decrease SNS outflow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

DOC for HTN in pregnancy

A

Methyldopa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Methyldopa Side effects

A

Hemolytic anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Prazosin

A

Alpha-adrenergic Antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Terazosin

A

Alpha-adrenergic Antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Doxazosin

A

Alpha-adrenergic Antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Alpha-adrenergic Antagonist Indications

A

Useful for treating HTN in men with BPH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Alpha-adrenergic Antagonist Side Effects

A

First dose phenomenon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Timolol

A

Non-selective Beta Blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Propanolol

A

Non-selective Beta Blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Nadolol

A

Non-selective Beta Blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Metoprolol

A

Beta 1 blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Atenolol

A

Beta 1 blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Nebivolol

A

Beta 1 blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Acebutolol

A

Beta 1 blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Beta Blocker effects

A

Decrease CO, renin secretion and SNS tone.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Beta Blocker Indications

A

Reduces mortality in CHF. Angina, Post-MI, Migraines.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Beta Blocker side effects

A

Blocks insulin release and inhibits recovery from hypoglycemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Beta Blocker contraindications

A

DM, asthma, heart block and end stage CHF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Carvedilol

A

Alpha and Beta Blocker

46
Q

Labetalol

A

Alpha and Beta Blocker

47
Q

Alpha and Beta Blocker MOA

A

Vasodilation without the reflex tachycardia or renin release

48
Q

Labetalol Indications

A

HTN emergencies. Acute and maintenance use in pregnancy.

49
Q

Carvedilol Inditations

A

HTN and CHF especially post-MI

50
Q

Alpha and Beta Blocker Side effects

A

Hepatotoxicity (especially labetalol)

51
Q

Vasodilator side effects

A

Reflex tachycardia, HA, fluching, palpitations. Long term lead to fluid retention.

52
Q

Hydralazine

A

Vasodilator that acts through NO.

53
Q

Hydralazine side effects

A

Lupus is slow acetylators

54
Q

Sodium Nitroprusside

A

Vasodialtor that acts through NO. Emergency HTN, IV only.

55
Q

Sodium Nitroprusside adverse effects

A

Metabolized by thiocyanate and causes cyandide accumulation

56
Q

Minoxidil MOA

A

Vasodilator that opens potassium channels to cause hyperpolarization and smooth muscle relaxation.

57
Q

Fenoldopam

A

D1 receptor agonist. Mainly effects the renal vasculature.

58
Q

Nifedipine

A

CCB dihydropine. Strongest vasodilatory effects so increases HR

59
Q

Verapamil

A

CCB with the strongest cardiac effects leading to a decreased HR

60
Q

Diltiazem

A

CCB with vasodilatory and cardiac effects.

61
Q

CCB contraindications

A

CHF. don’t use along with a nitrate.

62
Q

DOC for HTN in DM

A

ACE-I

63
Q

-prils

A

ACE-I

64
Q

DOC for HTN in CKD

A

ACE-I

65
Q

DOC for HTN in CHF

A

ACE-I

66
Q

ACE-I adverse effects

A

Increased bradykinin leading to dry cough and angioedema

67
Q

-sartans

A

ARBs

68
Q

ARBs MOA

A

Block the effects of angiotensin II without effecting Bradykinin (no cough or angioedema). Similar to ACE-I

69
Q

DOC For Acute Anginal Attack

A

Nitrates

70
Q

Nitrate indications

A

Acute use in classic and vasospastic. Long term maintenance in classic angina.

71
Q

Nitrate Side effects

A

Throbbing head aches

72
Q

Nitrate contraindications

A

Don’t use with sildenafil

73
Q

Monday’s disease

A

Frequent exposure to nitrates builds up tolerance. Not effective for long term treatment

74
Q

CCB indications

A

Treatment of HTN and angina

75
Q

Beta blockers and Angina

A

Decrease cardiac workload to decrease oxygen demand. Only useful in classic angina

76
Q

Ranolazine Indications

A

Refractory angina

77
Q

Sildenafil (viagra)

A

Phosphodiesterase type 5 inhibitor

78
Q

Sildenafil (viagra) Adverse effects

A

Blue visual disturbances

79
Q

Sildenafil (viagra) Contraindications

A

Use with an alpha blocker, nitrate or grapefruit juice

80
Q

Vardenafil (levitra)

A

Phosphodiesterase type 5 inhibitor. More selective for PD5 and faster onset of action.

81
Q

Tadalafil (cialis)

A

Phosphodiesterase type 5 inhibitor. More selective for PD5. Longer duration of action.

82
Q

Statin MOA

A

Structural analog for HMG-CoA reductase. Blocks de novo synthesis of cholesterorl in the liver causing and increase in high affinity LDL receptors which will decrease plasma levels.

83
Q

DOC for Decreasing LDL

A

Statins

84
Q

Statin effects

A

Decreases LDL and triglycerides while increasing HDL. Decreases CRP, lipoprotein oxidation and platelet aggregation. Increases NO production and plaque stability.

85
Q

Statin adverse effects

A

Increased LFTs (caution in patients will existing liver problems). Muscle pain that can lead to rhabdomyolysis.

86
Q

Statin Contraindications

A

pregnancy, Grapefruit juice.

87
Q

Statin drug interactions

A

gemfibrozil will inhibit their metabolism

88
Q

Chlestyramine

A

Bile acid binding resin

89
Q

Colestipol

A

Bile acid binding resin

90
Q

Colesevelam

A

Bile acid binding resin

91
Q

Bile acid binding resin MOA

A

inhibits bile acid reabsorption. Decrease LDL. No effect on familial hypercholesteremia

92
Q

Bile acid binding resin Side effects

A

Constipation and bloating. Impairs the absorption of fat soluble vitamins and other drugs.

93
Q

Niacin MOA

A

Inhibits VLDL secretion and increases HDL

94
Q

Niacin adverse effects

A

Cutaneous vasodilation due to prostaglandins (aspirin first)

95
Q

Gemfibrozil

A

Fibric Acid Derivative

96
Q

Fenofibrate

A

Fibric Acid Derivative

97
Q

Fenofibric acid

A

Fibric Acid Derivative

98
Q

Fibric Acid Derivative MOA

A

PPAR-alpha ligand receptor to upregulate LPL genes. Decrases Triglycerides.

99
Q

Fibric Acid Derivative Side effects

A

Gall stones

100
Q

Ezetimibe MOA

A

Blocks intestinal absorption of cholesteral. Synergistic with statins.

101
Q

Alirocumab

A

PCSK9

102
Q

Evolocumab

A

PCSK9

103
Q

PCSK9 MOA

A

Antibodies that inhibit LDL receptor breakdown. Given as a subcutaneous injection.

104
Q

Treatment of HTN with Angina

A

Beta-blocker

105
Q

Treatment of HTN post-MI

A

Beta blocker

106
Q

Treatment of HTN with asthma

A

CCB

107
Q

Treatment of HTN with DM

A

ACEI

108
Q

Treatment of HTN with CKD

A

ACEI

109
Q

Treatment of HTN with BPH

A

Alpha blocker

110
Q

Treatment of HTN with migraines

A

Beta blocker